Early recognition of cardiovascular disease
- Conditions
- Cardiovasculaire ziektenHart- en vaatziektenAtriumfibrillerenCoronairlijdenHartfalenCardiovascular diseaseatrial fibrillationcoronary artery diseaseheart failure
- Registration Number
- NL-OMON24396
- Lead Sponsor
- niversity Medical Center Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Not specified
- Target Recruitment
- 1300
Inclusion Criteria
1. Currently enrolled in a primary care (chronic) disease management program for either COPD or T2D
2. Age 18 years or over
Exclusion Criteria
1. Not proficient in Dutch or having severe cognitive impairment (i.e. not able to understand and correctly fill in the questionnaire)
2. Having a triple diagnosis of HF, CAD and AF. Confirmed with echocardiography in case of HF, with coronary angiography, exercise-test, stress-echo, stress MRI, SPECT-CT/MIBI or calcium score > 100 on CT-scan in case of CAD, with electrocardiography in case of AF.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number of newly detected cases with CVDs (heart failure, atrial fibrillation or coronary artery disease) in both arms, and the subsequent targeted therapies these new cases received.
- Secondary Outcome Measures
Name Time Method 1. the added diagnostic value of family history taking, and, in women, reproductive history<br /><br> 2. the added diagnostic value of biomarkers other than BNP, i.e. high-sensitive troponine (hs-Tn), growth differentiation factor 15 (GDF-15),ST-2?<br /><br> 3. the cost-effectiveness of the Early Diagnosis Strategy compared to usual care